Skip to content
Search

Latest Stories

Conditions & Symptoms

Dr. Nathalie Johnson Honored with the Impact Award at NCoBC 2025

Dr. Nathalie Johnson Honored with the Impact Award at NCoBC 2025

NCBC President Jennifer Plichta, MD, MS, FACS, CGRA, presents Dr. Nathalie Johnson, MD, FACS, with the 2025 Impact Award.

Las Vegas, NV – March 27, 2025 – Dr. Nathalie Johnson, a distinguished leader in breast cancer care and advocacy, was presented with the prestigious Impact Award at the NCoBC 2025 34th Interdisciplinary Breast Center Conference, held at Caesars Palace in Las Vegas. The NCBC Impact Award recognizes individuals whose pioneering contributions have significantly advanced breast cancer care, research, and advocacy.

The award was presented to Dr. Johnson by NCBC Board President, Jennifer Plichta, MD, MS, FACS, CGRA, in recognition of her unwavering commitment to improving breast cancer treatment, education, and patient care.


"The Impact Award recognizes an individual whose contributions have profoundly influenced breast cancer care, research, or advocacy. This year, we are proud to present this award to Dr. Nathalie Johnson, whose leadership and dedication have transformed the landscape of breast cancer treatment and education. Her tireless efforts have improved countless lives and established a standard of excellence that will inspire future generations," said Kimberly Samuels, Executive Director of NCBC.

Dr. Johnson's career includes a significant role as the Commissioner of Health for the U.S. Virgin Islands, where she worked to enhance public health initiatives. She was later recruited to Oregon to develop Legacy Health-Good Samaritan’s breast health centers and advance cancer patient care. As a past president of the American Society of Breast Surgeons, Dr. Johnson continues to serve on its Board of Directors. Beyond her clinical practice, she is actively involved in breast cancer research and has previously served on the Board of Directors for NCBC.

Receiving the Impact Award further solidifies Dr. Johnson’s status as a trailblazer in the field of breast cancer treatment and advocacy, marking another major achievement in her exceptional career.

About the NCBC: National Consortium of Breast Centers established in 1986:
A nonprofit organization dedicated to excellence in interdisciplinary breast health & oncology care for the general public.

More Stories

Tuberculosis Outbreak in Kansas: A Warning for the Nation
Photo by Josh Redd on Unsplash

Tuberculosis Outbreak in Kansas: A Warning for the Nation

A recent tuberculosis outbreak in Kansas has raised alarms among health officials, highlighting the persistent dangers of this infectious disease and its potential implications for the rest of the United States. The outbreak, primarily affecting Wyandotte and Johnson counties, is one of the largest recorded in U.S. history, with 67 active cases and 79 latent infections as of January 2025 (AP News). What does this mean for the rest of the country?

The Scope of the Outbreak

The outbreak has resulted in two confirmed fatalities in 2024, prompting a swift response from the Kansas Department of Health and Environment (KDHE) and the Centers for Disease Control and Prevention (CDC). The agencies have ramped up contact tracing, testing, and treatment efforts to contain the disease. Despite these efforts, the outbreak serves as a stark reminder of the challenges associated with TB control (AP News).

Keep ReadingShow less
6 Simple Steps Women Can Take to Lower Heart Disease Risk—No Pills Needed

6 Simple Steps Women Can Take to Lower Heart Disease Risk—No Pills Needed

Scope of the problem

Heart disease is largely preventable, yet, it remains the number 1 cause of death in women in the United States, claiming the lives of 1 in 3 women, more than breast cancer (1 in 25 to 30 women die of breast cancer) and more than all cancers combined. Unfortunately, these statistics haven’t changed much over time. Despite all the sophisticated advances in cardiovascular care, women under 65 years old are twice as likely as their male counterparts to die following a heart attack.

Keep ReadingShow less
Male Menopause: Fact or Fiction

Male Menopause: Fact or Fiction

As a family physician and wellness advocate, I often encounter questions about whether “male menopause” is a real phenomenon. While aging related hormone changes in men are a reality, they differ significantly from the changes women experience during menopause. Let’s unpack the facts, debunk myths, and explore the signs, symptoms, and treatment options for age related hormonal changes in men.

Hormonal Changes: A Natural Part of Aging

Keep ReadingShow less

Pancreatic Cancer: The Legacy of Patrick Swayze and the Fight for Better Treatments

What 80's kid didn't love Patrick Swayze? Johnny Castle, Bohdi, James Dalton, Vida Boheme, and pancreatic cancer patient. Less than two years after he was diagnosed, Patrick Swayze died. Pancreatic cancer is one of the most aggressive and challenging cancers to diagnose and treat, earning a reputation as one of the deadliest forms of cancer. Despite accounting for only about 3% of all cancers in the U.S., it ranks as the fourth leading cause of cancer-related deaths. Its high mortality rate makes it crucial to understand the factors behind its severity and the advancements being made to combat it 【1】【2】.

Why Is Pancreatic Cancer So Deadly?

  1. Late Diagnosis
    Pancreatic cancer is often referred to as a "silent killer" because symptoms usually appear only in advanced stages. Common signs, such as abdominal pain, jaundice, and weight loss, often overlap with other conditions, delaying diagnosis. By the time pancreatic cancer is detected, it has often spread to other organs, making treatment more difficult 【2】【3】.
  2. Aggressive Nature
    Pancreatic tumors are highly invasive and have a unique ability to metastasize quickly. The cancer often spreads to the liver, lungs, or surrounding blood vessels, further limiting treatment options 【3】.
  3. Resistance to Treatment
    Unlike some cancers that respond well to chemotherapy or radiation, pancreatic cancer is often resistant to these therapies. Its dense tissue environment, called the tumor microenvironment, acts as a barrier, protecting cancer cells from treatment 【4】.
  4. Genetic Complexity
    Pancreatic cancer exhibits numerous genetic mutations, which complicates the development of targeted therapies. This genetic diversity makes it challenging to identify universal treatment strategies 【5】.
  5. Low Survival Rates
    The five-year survival rate for pancreatic cancer is just 12%, one of the lowest among major cancers. However, early detection can significantly improve outcomes, with localized cases having a five-year survival rate of around 44% 【1】.

What Is Being Done to Improve Treatment?

Despite its challenges, significant progress is being made in pancreatic cancer research and treatment:

Keep ReadingShow less

Advancements and Hope During National Alzheimer’s Awareness Month

German psychiatrist Dr. Alois Alzheimer discovered Alzheimer's disease in 1906. He had a patient named Auguste Deter who suffered from memory loss, paranoia, and other psychological changes. After Deter died, Alzheimer examined her brain and found abnormal deposits and shrinkage around nerve cells, which are now known as amyloid plaques and tau tangles. Every November, National Alzheimer’s Disease Awareness Month draws attention to a condition that affects millions of lives and families across the United States. Established in 1983 by President Ronald Reagan, this observance aims to increase awareness about Alzheimer’s disease, highlight advancements in research, and inspire hope for a future free from its devastating effects.

Understanding Alzheimer’s Disease

Alzheimer’s disease is the most common cause of dementia, accounting for 60-80% of cases worldwide. It is a progressive neurological disorder that impairs memory, thinking, and behavior, ultimately making it difficult for individuals to carry out daily activities. Today, over 6.7 million Americans aged 65 and older live with Alzheimer’s, a number projected to nearly double by 2050 without medical breakthroughs 【1】【2】.

Keep ReadingShow less
×